| 1 |
32436611 | Clinical spectrum and prognostic value of TP53 mutations in circulating tumor DNA from breast cancer patients in China. | 2020 Jun |
1 |
| 2 |
23897043 | Validation of a yeast functional assay for p53 mutations using clonal sequencing. | 2013 Dec |
1 |
| 3 |
22445862 | Docetaxel and 5-fluorouracil induce human p53 tumor suppressor gene transcription via a short sequence at core promoter element. | 2012 Aug |
1 |
| 4 |
21570352 | TP53 status for prediction of sensitivity to taxane versus non-taxane neoadjuvant chemotherapy in breast cancer (EORTC 10994/BIG 1-00): a randomised phase 3 trial. | 2011 Jun |
1 |
| 5 |
21792013 | Expression of ERCC1, p53, and class III β-tubulin do not reveal chemoresistance in endometrial cancer: results from an immunohistochemical study. | 2011 Aug |
1 |
| 6 |
18230133 | TP53 status and taxane-platinum versus platinum-based therapy in ovarian cancer patients: a non-randomized retrospective study. | 2008 Jan 29 |
1 |
| 7 |
17720501 | Using specific cytotoxics with a targeted mind. | 2007 Dec |
2 |
| 8 |
16935784 | [Towards an individualization of systemic treatment of breast tumors]. | 2006 Aug |
1 |
| 9 |
18528466 | The individualization of cancer therapy: the unexpected role of p53. | 2006 |
1 |
| 10 |
12684687 | The effect of loss of Brca1 on the sensitivity to anticancer agents in p53-deficient cells. | 2003 May |
1 |
| 11 |
12769774 | Signal transduction pathways of taxanes-induced apoptosis. | 2003 Jul |
1 |
| 12 |
12771997 | Drug resistance associated with loss of p53 involves extensive alterations in microtubule composition and dynamics. | 2003 Jun 2 |
1 |
| 13 |
11284622 | Advances in the treatment of non-small cell lung cancer: molecular markers take the stage. | 2001 Feb |
1 |
| 14 |
11340581 | A role for loss of p53 function in sensitivity of ovarian carcinoma cells to taxanes. | 2001 Jun 1 |
1 |
| 15 |
28140079 | Advances in the treatment of non-small cell lung cancer: Molecular markers take the stage. | 2001 Feb |
1 |
| 16 |
11099323 | p53 gene status and response to platinum/paclitaxel-based chemotherapy in advanced ovarian carcinoma. | 2000 Dec 1 |
1 |
| 17 |
10210536 | Combination of taxanes with radiation: preclinical studies. | 1999 Apr |
1 |
| 18 |
10446979 | DNA damage increases sensitivity to vinca alkaloids and decreases sensitivity to taxanes through p53-dependent repression of microtubule-associated protein 4. | 1999 Aug 1 |
1 |
| 19 |
10541367 | Strategies for developing effective radioimmunotherapy for solid tumors. | 1999 Oct |
1 |
| 20 |
9030234 | [Apoptosis and chemosensitivity]. | 1997 Jan |
1 |